학술논문
RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents
Document Type
Article
Author
Elhabazi, K.; Humbert, J.-P.; Bertin, I.; Quillet, R.; Utard, V.; Ilien, B.; Simonin, F.; Schneider, S.; Schmitt, M.; Bourguignon, J.-J.; Bihel, F.; Laboureyras, E.; Ben Boujema, M.; Simonnet, G.; Ancel, C.; Simonneaux, V.; Beltramo, M.; Bucher, B.; Sorg, T.; Meziane, H.; Schneider, E.; Petit-Demoulière, B.
Source
In: Neuropharmacology . (Neuropharmacology, 15 May 2017, 118:188-198)
Subject
Language
English
ISSN
18737064
00283908
00283908